Free Trial

Achmea Investment Management B.V. Purchases 13,570 Shares of HCA Healthcare, Inc. (NYSE:HCA)

HCA Healthcare logo with Medical background

Achmea Investment Management B.V. lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 31.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,819 shares of the company's stock after purchasing an additional 13,570 shares during the period. Achmea Investment Management B.V.'s holdings in HCA Healthcare were worth $19,634,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Brighton Jones LLC bought a new position in HCA Healthcare in the fourth quarter worth about $1,021,000. Private Advisor Group LLC lifted its holdings in HCA Healthcare by 28.7% in the fourth quarter. Private Advisor Group LLC now owns 4,354 shares of the company's stock valued at $1,307,000 after acquiring an additional 972 shares during the period. Sigma Planning Corp grew its position in shares of HCA Healthcare by 25.9% during the 4th quarter. Sigma Planning Corp now owns 714 shares of the company's stock valued at $214,000 after acquiring an additional 147 shares during the period. Denali Advisors LLC increased its position in HCA Healthcare by 78.6% in the fourth quarter. Denali Advisors LLC now owns 2,500 shares of the company's stock worth $750,000 after buying an additional 1,100 shares in the last quarter. Finally, National Pension Service increased its stake in shares of HCA Healthcare by 3.6% in the fourth quarter. National Pension Service now owns 570,291 shares of the company's stock worth $171,173,000 after purchasing an additional 19,637 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on HCA. Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Royal Bank Of Canada restated an "outperform" rating and set a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a report on Monday. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Guggenheim initiated coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Seven equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $394.33.

View Our Latest Report on HCA Healthcare

Insider Activity at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 1.1%

HCA opened at $378.17 on Friday. The firm has a market cap of $90.98 billion, a P/E ratio of 16.81, a price-to-earnings-growth ratio of 1.29 and a beta of 1.49. The business has a 50 day moving average price of $365.66 and a 200 day moving average price of $336.33. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter last year, the company earned $5.36 EPS. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is presently 12.81%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines